Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1

Conditions

Febrile Neutropenia 4Neoplasms 3Neutropenia 2Fever 2Infections 1Hematologic Neoplasms 1Breast Neoplasms 1

Interventions

pegfilgrastim 3Vancomycin 2Teicoplanin 2Meropenem 2Filgrastim 2Ciprofloxacin 2Ceftazidime 2Cefepime 2posaconazole 1pegylated granulocyte colony-stimulating factor 1Vascular Access Devices 1Ofloxacin 1Metronidazole 1Leucovorin 1Lenograstim 1Irinotecan 1Fluorouracil 1Cilastatin, Imipenem Drug Combination 1Amikacin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Neutropenia × Vancomycin × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT00454272 2009-03-06

Comparison of Teicoplanin and Vancomycin in Initial Empirical Antibiotic Regimen for Febrile Neutropenic Patients

Sanofi

Phase 4 Completed
197 enrolled
Classical hematology

Fever, Infections, Neoplasms, Neutropenia, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡